HLA-G and hepatocellular carcinoma: However, it is unlikely that β2-microglobulin alone could act as a biomarker specifically for HCC as serum levels of β2-microglobulin are also elevated in patients with chronic inflammatory disease, viral disease (e.g. AIDS) and lymphomas (Cooper and Plesner, 1980).